SERA Sera Prognostics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SERA

Price (delayed)

$2.06

Market cap

$81.27M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.67

Enterprise value

$79.87M

?
Relative Growth: Rel. Growth: 27
Relative Strength: Rel. Strength: 34
Relative Valuation: Rel. Valuation: 1
Relative Profitability: Rel. Profitability: 8
Highlights
The gross margin has grown by 22% from the previous quarter
Sera Prognostics's gross profit has increased by 3.7% QoQ
Sera Prognostics's revenue has decreased by 35% YoY but it has increased by 23% from the previous quarter
SERA's EPS is up by 21% year-on-year but it is down by 3.1% since the previous quarter
The equity has declined by 33% year-on-year and by 12% since the previous quarter
Sera Prognostics's debt has increased by 20% from the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://seraprognostics.com

Key stats

What are the main financial stats of SERA

SERA stock price

How has the Sera Prognostics stock price performed over time
Intraday
-3.29%
1 week
1.98%
1 month
-3.74%
1 year
-33.33%
YTD
-30.17%
QTD
13.19%

Financial performance

How have Sera Prognostics's revenue and profit performed over time
Revenue
$70,000
Gross profit
-$105,000
Operating income
-$37.3M
Net income
-$33.23M
Gross margin
-150%
Net margin
-47,475.7%
Sera Prognostics's net margin has plunged by 57% YoY but it has increased by 16% from the previous quarter
Sera Prognostics's operating margin has shrunk by 56% YoY but it has increased by 17% QoQ
Sera Prognostics's revenue has decreased by 35% YoY but it has increased by 23% from the previous quarter
The gross margin has grown by 22% from the previous quarter

Price vs fundamentals

How does SERA's price correlate with its fundamentals

Growth

What is Sera Prognostics's growth rate over time

Valuation

What is Sera Prognostics stock price valuation
P/E
N/A
P/B
1.36
P/S
1,485.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1,140.98
SERA's EPS is up by 21% year-on-year but it is down by 3.1% since the previous quarter
The equity has declined by 33% year-on-year and by 12% since the previous quarter
The price to book (P/B) is 26% lower than the 5-year quarterly average of 1.9 but 8% higher than the last 4 quarters average of 1.3
Sera Prognostics's revenue has decreased by 35% YoY but it has increased by 23% from the previous quarter
SERA's P/S is 12% above its 5-year quarterly average of 1374.9 but 4.5% below its last 4 quarters average of 1608.3

Efficiency

How efficient is Sera Prognostics business performance
SERA's return on sales has dropped by 57% year-on-year but it is up by 16% since the previous quarter
The company's return on equity fell by 14% QoQ
The ROIC has contracted by 11% from the previous quarter but it has grown by 5% YoY
The company's return on assets fell by 10% QoQ

Dividends

What is SERA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SERA.

Financial health

How did Sera Prognostics financials performed over time
SERA's total assets is down by 22% year-on-year and by 7% since the previous quarter
Sera Prognostics's total liabilities has increased by 16% YoY and by 6% QoQ
Sera Prognostics's debt is 95% less than its equity
The equity has declined by 33% year-on-year and by 12% since the previous quarter
SERA's debt to equity is up by 25% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.